source
- AstraZeneca signs $1.5B AI partnership with insitro to discover liver and heart disease targetsAstraZeneca announced a partnership with insitro, a biotech that uses artificial intelligence, with an upfront payment of $40 million and potential milestones up to $1.46 billion. The collaboratio…
- Iambic Therapeutics raises $150 million in IPO to fund oncology drug developmentIambic Therapeutics, a San Diego-based AI biotech, completed an initial public offering that raised $150 million, exactly meeting its goal of selling 9.4 million shares at $16 each. The company sa…